TPA in stroke pays for itself in health-care savings
American Heart Association (AHA)Clot-dissolver tissue plasminogen activator (TPA) can reduce the disability of people who survive an ischemic stroke, one caused by a clot that blocks an artery carrying blood to the brain. But given the drugÃs cost of over $2,000 a dose, are the benefits worth the money? Yes, according to a new study.